Home/Filings/4/0001441848-10-000022
4//SEC Filing

FACET BIOTECH CORP 4

Accession 0001441848-10-000022

CIK 0001441848operating

Filed

Apr 22, 8:00 PM ET

Accepted

Apr 23, 1:57 PM ET

Size

10.7 KB

Accession

0001441848-10-000022

Insider Transaction Report

Form 4
Period: 2010-04-21
LYONS GARY A
Director
Transactions
  • Disposition to Issuer

    Common Stock

    2010-04-21$27.00/sh2,500$67,5000 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-04-21$27.00/sh5,000$135,0000 total
    Exercise: $9.56Exp: 2010-05-26Common Stock (5,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-04-21$27.00/sh16,667$450,0090 total
    Exercise: $6.17Exp: 2016-01-23Common stock (16,667 underlying)
Footnotes (3)
  • [F1]These shares were canceled and exchanged for a cash payment of $67,500.00 in accordance with the Agreement and Plan of Merger, dated March 9, 2010, among the issuer, Amber Acquisition Inc. and Abbott Laboratories in connection with the merger of Amber Acquisition Inc. with and into the issuer.
  • [F2]This stock option was canceled and exchanged for a cash payment of $347,173.61 in accordance with the Agreement and Plan of Merger, dated March 9, 2010, among the issuer, Amber Acquisition Inc. and Abbott Laboratories in connection with the merger of Amber Acquisition Inc. with and into the issuer. The cash payment made with respect to this stock option equals the product of (x) the number of option shares canceled multiplied by (y) the difference between the merger consideration ($27 per share) and the exercise price for this stock option.
  • [F3]This stock option was canceled and exchanged for a cash payment of $87,200.00 in accordance with the Agreement and Plan of Merger, dated March 9, 2010, among the issuer, Amber Acquisition Inc. and Abbott Laboratories in connection with the merger of Amber Acquisition Inc. with and into the issuer. The cash payment made with respect to this stock option equals the product of (x) the number of option shares canceled multiplied by (y) the difference between the merger consideration ($27 per share) and the exercise price for this stock option.

Issuer

FACET BIOTECH CORP

CIK 0001441848

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001441848

Filing Metadata

Form type
4
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 1:57 PM ET
Size
10.7 KB